Back to Search
Start Over
Precision BioSciences Closes License Deal with TG Therapeutics
- Source :
- Entertainment Close-up. January 30, 2024
- Publication Year :
- 2024
-
Abstract
- Precision BioSciences, an advanced gene editing company utilizing its novel proprietary ARCUS platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Entertainment Close-up
- Publication Type :
- Periodical
- Accession number :
- edsgcl.780995708